(Q43237187)

17 November 2017

title

Gram-negative bloodstream infections (English)

1 reference

17 November 2017

main subject

Gram-negative bacteria

0 references

1

Martin E Stryjewski

1 reference

17 November 2017

Helen W Boucher

2

1 reference

17 November 2017

publication date

1 January 2009

1 reference

International Journal of Antimicrobial Agents

17 November 2017

published in

1 reference

17 November 2017

volume

34 Suppl 4

1 reference

17 November 2017

page(s)

S21-5

1 reference

The epidemiology of sepsis in the United States from 1979 through 2000

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Reemergence of gram-negative health care-associated bloodstream infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Bloodstream infection-associated sepsis and septic shock in critically ill adults: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Epidemiology of early-onset bloodstream infection and implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Non-HACEK gram-negative bacillus endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Extended-spectrum beta-lactamases in North America, 1987-2006.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Prevalence and clonality of extended-spectrum beta-lactamases in Asia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Prevalence of extended-spectrum beta-lactamases in South America

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Extended-spectrum beta-lactamases and clinical outcomes: current data

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

The new beta-lactamases.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudmonas aeruginosa on length of hospital stay

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Clinical impact of infections caused by ESBL-producing E. coli and K. pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Attributable mortality of nosocomial Acinetobacter bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Colistin and polymyxin B in critical care.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Efficacy and safety of cefepime: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Cefepime therapy and all-cause mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Tigecycline for treating bloodstream infections: a critical analysis of the available evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

1 reference

7 January 2021

Ceftobiprole: an extended-spectrum anti-methicillin-resistant Staphylococcus aureus cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2809%2970561-8

7 January 2021

10.1016/S0924-8579(09)70561-8

Identifiers

DOI

1 reference

17 November 2017

1 reference